Institute of Biomedical Research Corporation New (PK) (MRES) Quote

Nice buy double L, at a great price! Cheers!!

He hasn't delivered shit yet. I'm so bagged on this I wish he would. Remember the Wuhan delivery?

you'll retire off that alone

I added 1.16m today. Very pleased to add them to my pile.

You badmouth Jeff like that?

You will wish you averaged down instead of your group dropping em off all the way back down here. Building an incredible monster.

You should be buying every share you can.

Tick Tock... you've been warned.

Your followers are going to hate you for this.

Jeff has always delivered. Maybe not in your preferred timing but... you'll see.

This thing has become a trash fire. So many big things and plunk into the crapper.

One of Jeff's endless worthless tweets today is to notify that the CEO of Nike resigned today due to sinking sales. What about CEO's of company's with sinking share price??????????

REMEMBER THE WUHN

I personally like it. He said it was an amazing collaboration, short and long term building things for MRES and RLAB. He said we would be hearing more about it.

Definition of collaboration from Google search lol - "a partnership: a union; the act of producing or making something together. To collaborate is to commit to the possibility of producing an outcome greater than one that would be developed in a silo.."

FWIW, if anything A snippet from our fearless leader I had a very productive day at Google Dubai with my colleague Tiago Henriques. We met some 15 years ago when we lived in Barcelona, and now we are both here in Dubai.
Tiago heads up AI/ML Cloud for Google, Europe, the Middle East, and Africa.
For the 99%, AI has exploded onto the… pic.twitter.com/dcDX8S6hYR— Jeff Robinson, CEO and Chairman of $MRES and $RLAB (@contrariansmind) September 18, 2024

Last I checked, the kiddos are back at school. Where is the great news?

The damn thing hardly even trades anymore.

How much p/e value do you attribute to a company, whose CEO is fixated on sending tweets
of guys in their underwear LOL

REMEMBER THE WUHN

Can't uplist to OTCN under a penny. He going to do RS?

financials are posted through June 2024. They aren't behind..

OTC markets is showing pink limited still.

MRES is current from what I see and they are working on uplisting as Jeff tweeted..

Can someone explain to me why we’re not current yet when the financial was posted August 14? Am I missing something? Thanks

I hope he gets it done. I want to get out of this but not taking a 40 pct haircut. Haven't been following it tho. Just hoping for a little pop to escape

What’s your take on the financials with this and rlab he says are getting done for uplist? Could that be factoring in the silence for now? It’s been what like 6 plus weeks now since all the back and forth on x about shit

Not an axe. I still in this pos. Dead in the water. He was a man on a mission and went dead silent. I'm bagged

Frankie out here with an axe to grind against Jeff.. like he wasn't pumping this turd for the past year.

Zero volume. Time for more videos. Starbucks? Purple tea? MMA? Pick a card any card

They keep changing directions so you have to look both ways

They keep changing directions so you have to look both ways

Why does this have a yield sign?
Quarterly was filed

More markets will open up without the CBD especially in the US. States in the US all have different rules including how it's packaged. They are moving away from those regulation issues. This is positive imo..

They are trying to put a nice spin on it, but to me seems to be a big disappointment. Wasn't the whole thrust of their "advantage" because this was CBD infused? Who will buy their product if it is just regular?

CAPE TOWN, WESTERN CAPE, SOUTH AFRICA, August 22, 2024 /EINPresswire.com/ -- The Institute of Biomedical Research Corp. (OTC PINK: MRES), a pioneering nutraceutical biotechnology company that delves into the innovative realm of plant-based medicines, healthy food products, and sustainable packaging solutions, is pleased to announce the following updates with its M2Bio Food and Beverage division:

M2Bio Food and Beverage, known for its premium, healthy, and sustainably sourced products, is taking a significant step forward by announcing a strategic shift in its product lineup. After several successful years of exploring CBD-infused food products, the company has decided to discontinue this line and refocus efforts on expanding its core offerings.

This decision is rooted in the complex scientific and regulatory landscape surrounding CBD. While CBD has shown promise in various health applications, particularly in its anti-inflammatory and neuroprotective effects, the challenges associated with its use in food products have proven to be substantial. Research indicates that the bioavailability of CBD when ingested in food can vary widely, leading to inconsistent dosing and efficacy. Furthermore, the ongoing global debate and regulatory uncertainty over the classification of CBD as a food ingredient have added complexity to its marketability.

“We’ve always been committed to innovation, and our foray into the CBD space was driven by a desire to explore its potential benefits in food products,” says M2Bio Food and Beverage CEO Michael Sachar. “However, it’s just as important to recognize when the scientific, regulatory, and logistical challenges outweigh the benefits. By pivoting away from CBD in our food products, we can streamline our operations and focus on what we do best—delivering high-quality, sustainably sourced foods that our customers trust and love.”

This strategic pivot is a response to the challenges encountered and an opportunity to enhance the company’s offerings further. The Liviana® product line, known for its premium, organic ingredients, is poised to benefit from this refocus. Without the complications associated with CBD, M2Bio Food and Beverage anticipates broader distribution opportunities, particularly in international markets where CBD restrictions have previously posed significant barriers.

While the company is stepping back from CBD in food, its commitment to research and development in the health and wellness sector remains steadfast. M2Bio Food and Beverage will continue to explore the therapeutic potential of CBD in topical applications, particularly for pets suffering from skin conditions. Early studies suggest that CBD’s anti-inflammatory properties could relieve pets with dermatitis, a common and often chronic condition.

Jeff Robinson, CEO of M2Bio Sciences, commented on the scientific considerations driving this decision: “The bioavailability and pharmacokinetics of CBD when incorporated into food products present significant challenges. Our research indicates that achieving consistent therapeutic outcomes through ingestion is complex due to variability in absorption and metabolism. By redirecting our focus away from CBD-infused foods, we are positioning ourselves to advance in areas where we can more reliably control and optimize the health benefits of our products. This shift also opens up the entire global market to us, free from the regulatory constraints and distribution barriers that CBD imposed, allowing us to bring our products to consumers worldwide with greater ease and efficiency.”

As M2Bio Food and Beverage embarks on this new chapter, the company is? very optimistic about the future. This strategic decision will unlock new growth opportunities, allowing the company to deliver greater value to its customers, partners, and shareholders.

$RLAB $MRES Awesome update! Get those kiddies off to school and let's Rock! Woot Woot! https://t.co/fFiaOcrDjW— widgetinvestor (@jdcpa123) August 12, 2024

M2 Mikey tweets 2 days in a row about product launches with Liviana Foods/Rand Capital and now Teas. Love it!

teas More updates from M2Mikee today about the Green, Purple, and White teas. $mres @livianahealth @M2Biome pic.twitter.com/pKf9RYdY22— M2Bio Sciences: $MRES & $RLAB (@m2bio) August 8, 2024

Excellent video and love the update!

Here is the video It sounds like something is cooking with @livianahealth - We are about a month away...10 SKUs to start. $mres pic.twitter.com/AKQQQqwC3k— M2Bio Sciences: $MRES & $RLAB (@m2bio) August 7, 2024

Thanks for the update.
Did not know these things.

They posted a video on X stating within a month their healthy food brands. 10 SKU s will be selling at Rand capitals Starbucks. And about a month ago posted a video they are working on financials for an otc QB uplist. Stated takes a couple months. That was 4 weeks ago and don’t know how long they were previously working on it. I’m assuming for this quarter to have everything out. Hence the late filings. That’s for MRES and for RLAB uplist also

842k Somebody sees or knows something?
Or someone seeing a value opportunity here.

Some share trading hands here.
Quick check on News I saw nothing.

Another day of zero volume in this deserted ghost town. Maybe Jeff can blame the flippers some more. Coward.

That's a good one - Not!

Jeff must be disheartened that they chose Hulk Hogan at the RNC instead of one of his Muay Thai people. 😀

Excellent update. Great company

Company/ies update that applies to both $mres and $rlab @M2MMAofficial
If you have any questions, please feel free to ask. pic.twitter.com/XKrPeT0an2— M2Bio Sciences: $MRES & $RLAB (@m2bio) July 10, 2024

sheeesh whoever is running M2Bio's twitter page is a sensitive nancy. Oh well, at least shareholders' chirping finally got some sort of response out of them.

Based on all his ridiculous tweets, I have the feeling this company is just a hobby for him.

Anyone else find the person running the M2BIO twitter account to be snarky jerk? I suspect its Jeff Robinson, himself. The ego on that guy.. uhh yea, Jeff, we are questioning the stock. Its down about 80% in a year. Give us some F'n news and quit sharing news articles. Nobody cares about that stuff.

Time will come PPS will go much higher . Just a matter of time

Wow This is really going to get stock price moving
Exciting Progress Alert!

We’re thrilled to share that the M2Bio Sciences sign has been officially mounted at the new office!

This marks a significant milestone in our journey, symbolizing the incredible strides we’re making towards a brighter, innovative future. #Progress pic.twitter.com/hZGN0xB7EG— M2Bio Sciences: $MRES & $RLAB (@m2bio) July 5, 2024

Almost a million shares just traded at .0045

And this one is the deadest. As they say: Always be the best at what you do

REMEMBER THE WUHN

.0054 X .0066....most of the pennies are dead. Luckily this is the only one I'm stuck in....tax write off I guess. 😟

Even stock touters, err I mean paid CONsultant that people worship, don't like MRES.

From X...

"$MRES LMFAO!!! I knew that CEO was full of sh t LONG ago."